Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy

Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy

Cheng Wang,1,* Min Han,1,2,* Xuerong Liu,1 Shaoqing Chen,1 Fuqiang Hu,1 Jihong Sun,3 Hong Yuan1 1Department of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; 2Hangzhou Zhongmei Huadong Pharmaceutical Co, Ltd, Hangzhou 310011, China; 3Department of Ra...

Full description

Bibliographic Details
Main Authors:	Wang C, Han M, Liu X, Chen S, Hu F, Sun J, Yuan H
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-02-01
Series:	International Journal of Nanomedicine
Subjects:	mitoxantrone water responsive hybrid nanoparticles amorphous calcium carbonate cancer therapy
Online Access:	https://www.dovepress.com/mitoxantrone-preloaded-water-responsive-phospholipid-amorphous-calcium-peer-reviewed-article-IJN

Similar Items

Improved anticancer efficiency of Mitoxantrone by Curcumin loaded PLGA nanoparticles targeted with AS1411 aptamer
by: Maryam Hashemi, et al.
Published: (2021-01-01)

Mitoxantrone-Induced Suicidal Erythrocyte Death
by: Markus Arnold, et al.
Published: (2014-11-01)

Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone
by: Yao Chen, et al.
Published: (2018-07-01)

Size-Controlled Preparation and Behavior Study of Phospholipid–Calcium Carbonate Hybrid Nanoparticles
by: Wang C, et al.
Published: (2020-06-01)

Mitoxantrone in secondarily progressive multiple sclerosis: a series of 18 patients Mitoxantrone na esclerose múltipla secundária progressiva relato de 18 casos
by: María Belén Montú, et al.
Published: (2005-06-01)

Acute myeloid leukaemia induced by mitoxantrone: case report Leucemia mielóide aguda induzida por mitoxantrone: relato de caso
by: Walter Oleschko Arruda, et al.
Published: (2005-06-01)

A diperiodatoargentate(III)-based chemiluminescence determination of mitoxantrone in pharmaceutical preparations and human serum
by: Lili Xue, et al.
Published: (2021-04-01)

Late cardiotoxicity in MS patients treated with mitoxantrone
by: Jamshid Najafian, et al.
Published: (2019-01-01)

Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia
by: Kambere Amerigos Daddy J.C., et al.
Published: (2020-02-01)

Amorphous calcium phosphate nanoparticles-based mouthwash: preparation, characterization, and anti-bacterial effects
by: Kimiya Pakravanan, et al.
Published: (2019-07-01)

Modified Photochemical Properties of Mitoxantrone by Plasmonic Photothermal Response of Hollow Gold Nanoshells
by: Armin Imanparast, et al.
Published: (2019-01-01)

Combined percutaneous ethanol injection and mitoxantrone versus radiofrequency ablation in the treatment of hepatocellular carcinoma
by: Besher Helmy, et al.
Published: (2016-12-01)

Mitoxantrone-Surfactant Interactions: A Physicochemical Overview
by: Mirela Enache, et al.
Published: (2016-10-01)

Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer
by: Johann de Bono, et al.
Published: (2016-03-01)

Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer
by: Gianpaolo Perletti
Published: (2016-03-01)

Mitoxantrone removal by electrochemical method: A comparison of homogenous and heterogenous catalytic reactions
by: Abbas Jafarizad, et al.
Published: (2017-08-01)

The impact of mitoxantrone on neurological disability in active multiple sclerosis patients
by: Mesaroš Šarlota, et al.
Published: (2004-01-01)

Directing Stem Cell Commitment by Amorphous Calcium Phosphate Nanoparticles Incorporated in PLGA: Relevance of the Free Calcium Ion Concentration
by: Olivier Gröninger, et al.
Published: (2020-04-01)

Use of Mitoxantrone in Early Secondary Progressive Multiple Sclerosis: An Observational Study of 48 Patients with Clinical and MRI Outcomes
by: Ahmet Kasım Kılıç, et al.
Published: (2009-06-01)

The effect difference of chitosan nanoparticles, chitosan microparticles, and casein phosphopeptide–amorphous calcium phosphate in reducing enamel demineralization
by: Mohammad Chair Effendi, et al.
Published: (2020-01-01)

Mitoxantrone – an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis
by: Marzena Szwed
Published: (2014-02-01)

Mitoxantrone – an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis
by: Marzena Szwed
Published: (2014-02-01)

Targeting Mitochondrial Calcium Uptake with the Natural Flavonol Kaempferol, to Promote Metabolism/Secretion Coupling in Pancreatic β-cells
by: Flavien Bermont, et al.
Published: (2020-02-01)

Effects of pirarubicin and mitoxantrone for bladder cancer perfusion chemotherapy on the expression of malignant molecules in serum and lavage fluid
by: Wei Jiang, et al.
Published: (2018-12-01)

Binding mechanism of anti-cancer chemotherapeutic drug mitoxantrone to DNA characterized by magnetic tweezers
by: Dennis Kreft, et al.
Published: (2018-07-01)

Suspension of Amorphous Calcium Phosphate Nanoparticles Impact Commitment of Human Adipose-Derived Stem Cells In Vitro
by: Petra Wolint, et al.
Published: (2021-07-01)

High performance liquid chromatographic analysis of mitoxantrone in biological samples and preliminary pharmacokinetic studies in dogs and human cancer patients /
by: Cox, Steven Ray
Published: (1980)

A Precise Nanostructure of Folate-Overhung Mitoxantrone DNA Tetrahedron for Targeted Capture Leukemia
by: Ying-Zi Bu, et al.
Published: (2020-05-01)

Stabilized Amorphous Calcium Carbonate as a Precursor of Microcoating on Calcite
by: Taeyoung Jeon, et al.
Published: (2020-08-01)

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study
by: Nasim Tabrizi, et al.
Published: (2012-01-01)

Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-06-01)

Effect of L-carnitine against acute mitoxantrone toxicity in mice
by: Niang Mohamed, et al.
Published: (2008-09-01)

Inflammation as a Possible Trigger for Mitoxantrone-Induced Cardiotoxicity: An In Vivo Study in Adult and Infant Mice
by: Ana Reis-Mendes, et al.
Published: (2021-05-01)

Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
by: Tsilikas Christodoulos, et al.
Published: (2004-05-01)

Efficacy and toxicity of mitoxantrone and oral etoposide in the treatment of hormone-refractory prostate cancer: pilot study
by: Rafael Kaliks, et al.
Published: (2010-09-01)

First detection, characterization, and application of amorphous calcium phosphate in dentistry
by: Jie Zhao, et al.
Published: (2012-12-01)

Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor
by: Xu Y, et al.
Published: (2017-10-01)

The Increment of Genoprotective Effect of Melatonin due to “Autooptic” Effect versus the Genotoxicity of Mitoxantrone
by: M Zamani, et al.
Published: (2020-12-01)

Antiviral activity of mitoxantrone dihydrochloride against human herpes simplex virus mediated by suppression of the viral immediate early genes
by: Qiang Huang, et al.
Published: (2019-12-01)

Clinical efficacy of casein phosphopeptide - amorphous calcium phosphate and casein phosphopeptide-amorphous calcium fluoride phosphate and their influence on the quality of life in patients with Sjögren’s syndrome
by: Perić Tamara, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_1ro7sgvp18g00c5jnthhke8n0a